EYE-503: A Novel Retinoic Acid Drug for Treating Retinal Neurodegeneration
Retinal neurodegeneration is a major cause of vision loss. Retinoic acid signaling is critical for the maintenance of retinal function, and its dysfunction can cause retinal neurodegeneration. However, the therapeutic effects of retinoic acid drugs on retinal neurodegeneration remain unclear. In thi...
Saved in:
Main Authors: | Sha Liu (Author), Yuke Ji (Author), Huan Li (Author), Ling Ren (Author), Junya Zhu (Author), Tianjing Yang (Author), Xiumiao Li (Author), Jin Yao (Author), Xin Cao (Author), Biao Yan (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neurodegeneration and Neuroprotection in Retinal Disease
Published: (2020) -
Biomarkers of Neurodegeneration and Precision Therapy in Retinal Disease
by: Alessandra Micera, et al.
Published: (2021) -
Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease
by: Francesco Petrillo, et al.
Published: (2021) -
Dipeptide alanine-glutamine ameliorates retinal neurodegeneration in an STZ-induced rat model
by: Yuhan Zhang, et al.
Published: (2024) -
Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease, Volume II
by: Claudio Bucolo, et al.
Published: (2022)